Amwell (AMWL) reiterated its guidance for 2024, which calls for revenue in the range of $247M-$252M, adjusted EBITDA in the range of (137M)-(142M) and AMG visits between 1.4M-1.5M.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMWL:
- Amwell divests virtual psychiatric care business for $21M and added earn-out
- Amwell Expands CFO Role Amid Leadership Transition
- Amwell COO Kurt Knight, chief commercial growth officer Kathy Weiler to depart
- Amwell price target lowered to $10.50 from $20 at Morgan Stanley
- Amwell management to meet virtually with Truist